Amgen INC AMGEN ORD (CDI)/  US0311621009  /

London International
25/04/2024  19:06:01 Chg. - Volume Bid17:35:23 Ask17:35:23 Market Capitalization Dividend Y. P/E Ratio
268.25USD - 2,462
Turnover: 173,778.10
-Bid Size: - -Ask Size: - 172.03 bill.USD 2.70% 25.49

Fundamentals

  FY 2023 Growth (1Y)
Per Share  
Earnings per Share: 12.56 USD 3.12%
EPS Diluted: 12.49 USD 3.14%
Revenues per Share: 52.60 USD 6.70%
Book Value per Share: 11.63 USD 69.61%
Cash Flow per Share: 15.81 USD -13.17%
Dividend per Share: 8.64 USD 8.68%
Total in mill.  
Revenues: 28,190.00 USD 7.09%
Net Income: 6,717.00 USD 2.52%
Operating Cash Flow: 8,471.00 USD -
Cash and Cash Equivalents: 10,944.00 USD -

Valuation Ratios

  Current Latest FY*
P/E Ratio: 25.49 22.93
P/S Ratio: 6.09 5.48
P/BV ratio: 27.53 24.77
P/CF Ratio: 20.26 18.22
PEG: 8.17 7.35
Earnings Yield: 3.92% 4.36%
Dividend Yield: 2.70% 3.00%
Market Capitalization  
Market Capitalization: 172.03 bill. USD 154.36 bill. USD
Free Float Market Cap.: - USD - USD
Market Cap. / Employee: - USD - USD
Shares Outstanding: 537.33 mill.  
 

Profitability

Gross Profit Margin: 70.02%
EBIT Margin: 28.01%
Net Profit Margin: 23.83%
Return on Equity: 107.78%
Return on Assets: 6.91%

Financial Strength

Liquidity I / Cash Ratio: 0.60%
Liquidity II / Quick Ratio: 0.99%
Liquidity III / Current Ratio: 1.65%
Debt / Equity Ratio: 10.37%
Dynam. Debt / Equity Ratio: 1,073.33%

Efficiency

Employees: -
Personal Expenses / Employee: - USD
Revenues / Employee: - USD
Net Income / Employee: - USD
Total Assets / Employee: - USD
 
* Fiscal Year End: 31/12/2023
Accounting Standard: US GAAP
Currency: USD